Please assess the completion status of the following clinical trial:

Trial Title: A Study of Efficacy of Rituximab [Mabthera/Rituxan] in Patients With Rheumatoid Arthritis Using Magnetic Resonance Imaging of the Hand (RESONAR)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients, 18-75 years of age~* active rheumatoid arthritis (DAS28-CRP\>3.2)~* refractory to one or more anti-TNF~* on stable treatment for RA for \>/=4 weeks~* evidence of erosive disease and/or synovitis in wrist and/or knuckles~Exclusion Criteria:~* active systemic or local infection~* previous or current history of any demyelinization process in central nervous system, pancytopenia or aplasic anaemia~* signs of immunodeficiency, HIV infection or tuberculosis~* contraindications to MRI, such as metal devices, claustrophobia, moderate or severe renal insufficiency, or allergy to contrast agent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): None
- B (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).